Brief: Avadel Pharmaceuticals Says DC Court Of Appeals Upholds FDA Approval Of LUMRYZ - SEC Filing
June 27 (Reuters) - Avadel Pharmaceuticals PLC AVDL.O: AVADEL PHARMACEUTICALS PLC - D.C. COURT OF APPEALS UPHOLDS FDA APPROVAL OF LUMRYZ - SEC FILING Source text: [ID:n0001104659-25-063606] Further company coverage: AVDL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avadel Pharmaceuticals
See all newsBrief: Alkermes PLC Completes Acquisition Of Avadel Pharmaceuticals PLC, Accelerating Entry Into Sleep Medicine Market
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 08:10 AM
H Lundbeck steps down from takeover for Avadel, shares rise 3%
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet